RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • Dipeptidyl peptidase-4 inhibitors and cancer risk in patients with type 2 diabetes: a meta-analysis of randomized clinical trials

Dipeptidyl peptidase-4 inhibitors and cancer risk in patients with type 2 diabetes: a meta-analysis of randomized clinical trials

Add to Collection
Systematic Review and Meta Analysis M Zhao, J Chen, Y Yuan, Z Zou, X Lai, DM Rahmani… - Scientific Reports, 2017 - nature.com

Chapter : Section1
Journal Year : 2017
Cited by : 41.0

… The adverse events of cancers were classified into 10 types based on the location of the … that treat type 2 diabetes effectively. The advantages of using DPP4i for diabetes therapy are …..... Read More

Keywords : ["randomized clinical trial", "type diabetes", "dipeptidyl inhibitor", "cancer risk", "patient", "metaanalysis"]
PubMed Link : https://www.nature.com/articles/s41598-017-07921-2
Google Scholar Link : https://scholar.google.com/scholar?cites=9197838081965910841&as_sdt=5,39&sciodt=0,39&hl=en&num=20